These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2716 related items for PubMed ID: 10604340

  • 1. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H.
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [Abstract] [Full Text] [Related]

  • 2. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L, Poulos CK, Pan CX, Jones TD, Daggy JK, Eble JN, Koch MO.
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
    Makarov DV, Sanderson H, Partin AW, Epstein JI.
    J Urol; 2002 Jun; 167(6):2440-2. PubMed ID: 11992053
    [Abstract] [Full Text] [Related]

  • 7. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
    Poulos CK, Daggy JK, Cheng L.
    Cancer; 2004 Aug 01; 101(3):527-32. PubMed ID: 15274065
    [Abstract] [Full Text] [Related]

  • 8. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A, Nakashima J, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M.
    Prostate; 2003 Jun 15; 56(1):23-9. PubMed ID: 12746843
    [Abstract] [Full Text] [Related]

  • 9. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
    Grossfeld GD, Chang JJ, Broering JM, Li YP, Lubeck DP, Flanders SC, Carroll PR.
    J Urol; 2001 Mar 15; 165(3):851-6. PubMed ID: 11176485
    [Abstract] [Full Text] [Related]

  • 10. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC.
    Cancer; 2003 Dec 01; 98(11):2344-50. PubMed ID: 14635068
    [Abstract] [Full Text] [Related]

  • 11. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
    Park EA, Lee HJ, Kim KG, Kim SH, Lee SE, Choe GY.
    Int J Urol; 2007 Aug 01; 14(8):704-8. PubMed ID: 17681059
    [Abstract] [Full Text] [Related]

  • 12. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2000 Nov 01; 164(5):1596-600. PubMed ID: 11025712
    [Abstract] [Full Text] [Related]

  • 13. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
    Gao X, Mohideen N, Flanigan RC, Waters WB, Wojcik EM, Leman CR.
    J Urol; 2000 Dec 01; 164(6):1982-6. PubMed ID: 11061896
    [Abstract] [Full Text] [Related]

  • 14. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A, Tareen B, Lepor H.
    Prostate Cancer Prostatic Dis; 2009 Dec 01; 12(2):204-8. PubMed ID: 19238170
    [Abstract] [Full Text] [Related]

  • 15. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?
    Rubin MA, Mucci NR, Manley S, Sanda M, Cushenberry E, Strawderman M, Montie JE, Bassily NH.
    J Urol; 2001 Jan 01; 165(1):114-8. PubMed ID: 11125378
    [Abstract] [Full Text] [Related]

  • 16. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M.
    Urol Int; 2007 Jan 01; 78(4):328-33. PubMed ID: 17495491
    [Abstract] [Full Text] [Related]

  • 17. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.
    Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ.
    J Urol; 2005 Dec 01; 174(6):2164-8, discussion 2168. PubMed ID: 16280756
    [Abstract] [Full Text] [Related]

  • 18. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2005 Mar 01; 12(3):270-4. PubMed ID: 15828954
    [Abstract] [Full Text] [Related]

  • 19. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS, Cookson MS, Coffey CS, Vader V, Roberts RL, Chang SS, Smith JA, Shappell SB.
    J Urol; 2002 Aug 01; 168(2):519-24. PubMed ID: 12131301
    [Abstract] [Full Text] [Related]

  • 20. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.
    Cupp MR, Bostwick DG, Myers RP, Oesterling JE.
    J Urol; 1995 May 01; 153(5):1543-8. PubMed ID: 7714976
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 136.